Page 6,749«..1020..6,7486,7496,7506,751..6,7606,770..»

Cryo-Save Group N.V. awards researcher at grand opening of its new headquarters

Posted: Published on June 21st, 2012

The leading international family stem cell bank, Cryo-Save, celebrates the grand opening of its brand new headquarters office in Zutphen, the Netherlands, by honoring PhD. T.H.J. Nijhuis with the Young Investigator Award on June 22nd. Cryo-Save`s headquarters, located in Zutphen, the Netherlands, is celebrating the grand opening of its brand new, fully-renovated headquarters. On June 22nd, Arnoud van Tulder, CEO of Cryo-Save, and attorney-at-law C. Bieze, deputy in the province of Gelderland, will officially open the company`s new global headquarters office. To mark the occasion, the company will grant PhD. T.H.J. Nijhuis, winner of the Cryo-Save Young Investigator Award, a prize of 5,000 euros. Mr. Nijhuis has focused his most recent research on umbilical cord mesenchymal stem cells and pursues his work at the Erasmus Medical Center, part of the Erasmus University of Rotterdam, the Netherlands. Arnoud van Tulder, CEO of Cryo-Save, says "We are proud to name Mr. T.H.J. Nijhuis, as the winner of the Cryo-Save Young Investigator Award. Research is a cornerstone of the stem cell industry, and it`s advancements like that of Mr. T.H.J. Nijhuis that makes us so optimistic for the future." As part of Cryo-Save`s educational and community outreach efforts, the Cryo-Save Young Investigator Award … Continue reading →

Comments Off on Cryo-Save Group N.V. awards researcher at grand opening of its new headquarters

LIFE Focuses on Stem Cell Research – Analyst Blog

Posted: Published on June 21st, 2012

Referenced Stocks: ILMN, LIFE, TMO Given the recent flurry of activities, it seems that Life Technologies Corporation ( LIFE ) is focused on strengthening its foothold in the field of stem cell research. The company recently signed a non-exclusive agreement with iPS Academia of Japan for its induced pluripotent stem (iPS) cell patent portfolio. Based on this agreement, the company will be able to expand its portfolio for the iPS cell research community. Besides, it is well placed to create iPS cells and differentiate them into various cell types to be used in drug discovery and pre-clinical research. The license also enables Life Technologies to provide creation, differentiation and screening services of iPS cell to scientists globally. We consider the agreement to be a significant achievement for the company in the field of stem cell research as iPS cells are gaining attention for use in the areas of drug discovery, disease research and other areas of biotechnology. The agreement with iPS Academia of Japan comes on the heels of the partnership with Cellular Dynamics International, the world's largest producer of human cells derived from iPS cells. The partnership will aim at commercializing a set of three new products optimized to … Continue reading →

Comments Off on LIFE Focuses on Stem Cell Research – Analyst Blog

LIFE Focuses on Stem Cell Research

Posted: Published on June 21st, 2012

Given the recent flurry of activities, it seems that Life Technologies Corporation (LIFE) is focused on strengthening its foothold in the field of stem cell research. The company recently signed a non-exclusive agreement with iPS Academia of Japan for its induced pluripotent stem (iPS) cell patent portfolio. Based on this agreement, the company will be able to expand its portfolio for the iPS cell research community. Besides, it is well placed to create iPS cells and differentiate them into various cell types to be used in drug discovery and pre-clinical research. The license also enables Life Technologies to provide creation, differentiation and screening services of iPS cell to scientists globally. We consider the agreement to be a significant achievement for the company in the field of stem cell research as iPS cells are gaining attention for use in the areas of drug discovery, disease research and other areas of biotechnology. The agreement with iPS Academia of Japan comes on the heels of the partnership with Cellular Dynamics International, the world's largest producer of human cells derived from iPS cells. The partnership will aim at commercializing a set of three new products optimized to consistently develop and grow human iPS cells … Continue reading →

Comments Off on LIFE Focuses on Stem Cell Research

Propecia Prescribed by Hair Restoration Firm, Despite Sexual Side Effect Risks

Posted: Published on June 21st, 2012

Hair-growth drug, Propecia, is being prescribed by a popular hair restoration firm, despite significant sexual side effects. The U.S. Food & Drug Administration (FDA) approved Propecia in 1997. In 1997, doctors, medical researchers, and hair-restoration expert, L. Lee Bosley voiced concern about the medications severe adverse reactions, said The Examiner. In fact, Bosley called Propecia a serious health concern. Today, Dr. Bosley allows his doctors to earnestly recommend Propecia to patients. Propecia (finasteride 1 mg) belongs to a class of drugs known as 5-alpha reductase inhibitors, or 5-ARIs, and is approved to treat male pattern baldness by preventing the conversion of androgen testosterone to DHT, a hormone critical to male sexual performance. Recently, a number of lawsuits have been filed by men claiming they developed long-lasting, sometimes permanent, sexual problems because of their finasteride use. Bosley Medical, self-described as The Worlds Most Experienced Hair Restoration Experts, issued a news release in 1997 entitled, Supposed Miracle Baldness Cure Creates Serious Health Concerns Among Hair Restoration Professionals, said The Examiner. The release quoted Dr. Bosley as saying The FDA has just approved a drug that has the capability to impair male sexual performance, creating the inability to achieve an erection [and] decreases … Continue reading →

Posted in Penis Enlargement | Comments Off on Propecia Prescribed by Hair Restoration Firm, Despite Sexual Side Effect Risks

Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility

Posted: Published on June 21st, 2012

FORT WORTH, Texas, June 20, 2012 /PRNewswire/ --Healthpoint Biotherapeutics today announced the company is planning a significant upgrade to its 80,000 square foot research and manufacturing facility in Ft. Worth. The new, state-of-the-art facilities will comprise 25,000 square feet of manufacturing infrastructure, labs and clean room space for the production of cell-based therapies. "We are very pleased to be embarking on this important and innovative initiative at our headquarters here in Fort Worth," noted Travis E. Baugh, President and Chief Operating Officer of Healthpoint Biotherapeutics. "The planned, ultra-modern facility will create an efficient platform to support our lead pipeline candidate, HP802-247, which recently completed a successful phase 2b study in venous leg ulcers. Importantly, the facility will also add critical capabilities as we look toward the promise of regenerative medicine." The facility upgrade comes as the company is engaged in developing a pipeline of next generation wound care therapies based on cell and cell-matrix biology. The advanced nature of the facility will provide efficient and scalable manufacturing capabilities to support both development and future commercialization, as well as create a unique environment for novel collaboration and identification of new technologies. Healthpoint Biotherapeutics is planning to invest approximately $60 million to … Continue reading →

Posted in Cell Medicine | Comments Off on Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility

CBR – World’s Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Posted: Published on June 21st, 2012

SAN BRUNO, Calif., June 20, 2012 /PRNewswire/ -- Twenty years ago this month, CBR (Cord Blood Registry) in partnership with the University of Arizona, processed the first cord blood stem cell sample in the world to be stored specifically for family use. Since 1992, the number of conditions treated with cord blood stem cells has greatly expanded, and so has CBR. Today, CBR is the largest family cord blood bank in the world with more than 425,000 samples in storage a population the size of a major city like Miami. What distinguishes the "city of individuals" with newborn stem cells banked at CBR is the exclusive opportunity to participate in a growing number of ground-breaking clinical trials. (Photo: http://photos.prnewswire.com/prnh/20120620/SF27549-INFO) (Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO) "As the leader and innovator in family banking, we believe every newborn deserves a healthy future and that we have a responsibility to lead the way," said Heather Brown, vice president of scientific & medical affairs at CBR. "Looking back, the creation of our bank allowed families for the first time to preserve a genetically-related source of newborn stem cells, ready and available if needed for a lifesaving transplant to regenerate a person's immune system after radiation or chemotherapy. … Continue reading →

Posted in Cell Medicine | Comments Off on CBR – World’s Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

CBR – World's Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Posted: Published on June 21st, 2012

SAN BRUNO, Calif., June 20, 2012 /PRNewswire/ -- Twenty years ago this month, CBR (Cord Blood Registry) in partnership with the University of Arizona, processed the first cord blood stem cell sample in the world to be stored specifically for family use. Since 1992, the number of conditions treated with cord blood stem cells has greatly expanded, and so has CBR. Today, CBR is the largest family cord blood bank in the world with more than 425,000 samples in storage a population the size of a major city like Miami. What distinguishes the "city of individuals" with newborn stem cells banked at CBR is the exclusive opportunity to participate in a growing number of ground-breaking clinical trials. (Photo: http://photos.prnewswire.com/prnh/20120620/SF27549-INFO) (Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO) "As the leader and innovator in family banking, we believe every newborn deserves a healthy future and that we have a responsibility to lead the way," said Heather Brown, vice president of scientific & medical affairs at CBR. "Looking back, the creation of our bank allowed families for the first time to preserve a genetically-related source of newborn stem cells, ready and available if needed for a lifesaving transplant to regenerate a person's immune system after radiation or chemotherapy. … Continue reading →

Posted in Cell Medicine | Comments Off on CBR – World's Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Stanford study shows opiates' side effects rooted in patients' genetics

Posted: Published on June 21st, 2012

Public release date: 20-Jun-2012 [ | E-mail | Share ] Contact: Ruthann Richter richter1@stanford.edu 650-725-8047 Stanford University Medical Center STANFORD, Calif. Genetics play a significant role in determining which patients will suffer the most from the disturbing side effects of opiates, commonly prescribed painkillers for severe to moderate pain, according to a new Stanford University School of Medicine study, which pinpoints nausea, slowed breathing and potential for addiction as heritable traits. "One of the most hated side effects of these opiates, nausea, is strongly inherited," said Martin Angst, MD, professor of anesthesia and one of two principal investigators for the new study, which explores individual variations in the response to opiate use. The study will be published online June 20 in Anesthesiology. Genetics also play a likely role in determining which patients will suffer from itchiness and sedation associated with the use of these powerful medications, which include morphine, methadone and oxycodone. "The study is a significant step forward in efforts to understand the basis of individual variability in response to opioids and to eventually personalize opioid treatment plans for patients," said Angst, director of the Stanford Human Pain Research Laboratory. "Our findings strongly encourage the use of downstream molecular … Continue reading →

Posted in Drug Side Effects | Comments Off on Stanford study shows opiates' side effects rooted in patients' genetics

US pharmacy major Walgreens to take over Boots

Posted: Published on June 21st, 2012

Racold Thermo eyes Rs.150 crore market Calcutta News.Net - Wednesday 20th June, 2012 Pune-based Racold Thermo Ltd. is planning to achieve three-fold growth in its solar heater business to Rs.1.5 billion, a company official said Wednesday here. "We are eyeing to achieve three-fold ... Calcutta News.Net - Wednesday 20th June, 2012 The West Bengal government is awaiting a response from the central government on its request to extend the Software Technology Park of India scheme to allow concessions to IT giant Infosys for a ... Calcutta News.Net - Wednesday 20th June, 2012 Police in Chandigarh arrested two people Wednesday evening and recovered a huge quantity of psychotropic drugs, a police officer said. The accused were arrested at a check-post and have been ... Calcutta News.Net - Wednesday 20th June, 2012 Over 350,000 lakh families in the capital are set to switch from kerosene oil to liquefied petroleum gas (LPG), Chief Minister Sheila Dikshit said Wednesday. "The Delhi cabinet has given its nod ... Calcutta News.Net - Wednesday 20th June, 2012 Original post: US pharmacy major Walgreens to take over Boots … Continue reading →

Posted in Wholesale Pharmacy | Comments Off on US pharmacy major Walgreens to take over Boots

Dangerous "bath salts" hit Syracuse area like a tornado, expert says

Posted: Published on June 21st, 2012

While walking her dogs, Dr. Elizabeth Berry sees brightly colored containers of bath salts littering Syracuses Elmwood Park. The illegal drug easily found on the Internet or from dealers for less than $30 an ounce has hit the community like a tornado, said Berry, a drug treatment psychologist at Crouse Hospital. Much different than traditional bath salts, this synthetic drug is so named because its sold in crystals and appears relatively harmless. Its very frightening, said Berry who has seen usage spike in the last six months. People (on the drug) get very paranoid, she said. Theyre very easily threatened, a very high level of aggression, hard to calm. Their reality testing is so impaired, theyre not reasonable. Their reactions dont make sense. Syracuses Upstate New York Poison Center, which covers 54 Upstate counties, has seen an explosion of so-called bath salts cases. Before 2011, there hadnt been a single case reported. In 2011, there were 118 cases. This year, there have already been 165 cases through mid-June. This month, Central New York authorities have linked three high-profile cases to bath salts: The bizarre behavior of people on bath salts makes them dangerous to others. The Miami man accused of … Continue reading →

Posted in Drug Dependency | Comments Off on Dangerous "bath salts" hit Syracuse area like a tornado, expert says

Page 6,749«..1020..6,7486,7496,7506,751..6,7606,770..»